When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AIMT - Aimmune: FDA Panel Nod Pushes Peanut Allergy Treatment One Step Closer To Potential Approval
Aimmune Therapeutics Inc.
Aimmune Therapeutics (AIMT) recently had an advisory panel convene to determine if its peanut allergy treatment Palforzia (AR101) should be recommended for approval. The final vote in terms of recommending possible approval of the drug was highly positive. The panel did back the safety of the drug; however, the label will have to include a black box warning. The thing is that this type of treatment, should it be approved by the FDA, will be a good way for patients to get over their peanut allergy. It is a large market opportunity in